🇺🇸 FDA
Patent

US 6624292

Processes for preparing clarithromycin polymorphs

expired A61PA61P31/04

Quick answer

US patent 6624292 (Processes for preparing clarithromycin polymorphs) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P31/04